Nevro Corp. v. Boston Scientific Corp., No. 18-2220 (Fed. Cir. Apr. 9, 2020)
From the Opinion
The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.
Nevro Corporation sued Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation (col- lectively, Boston Scientific) in the Northern District of Cal- ifornia, alleging infringement of eighteen claims across seven patents: U.S. Patent Nos. 8,359,102; 8,712,533; 8,768,472; 8,792,988; 9,327,125; 9,333,357; and 9,480,842.1 The asserted patents are directed to high-frequency spinal cord stimulation therapy for inhibiting an individual’s pain.2 According to the specification, conventional spinal cor…
Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error